Track topics on Twitter Track topics that are important to you
Biotheranostics, Inc. announces new data from studies for both of its proprietary molecular diagnostic tests, CancerTYPE ID and Breast Cancer Index to be presented on Saturday, June 2nd and Monday, Ju...
Analysis using Breast Cancer Index to Provide Resolution for Extended Treatment Decision-Making in Genomic Intermediate-Risk Patients Biotheranostics, Inc. announced...
Clinical Practice Guidelines Recognize Breast Cancer Index Clinical Utility Spans the Treatment Continuum for Patients with Early-Stage Estrogen Receptor Positive (ER+) Disease ...
bioTheranostics discovers, develops, and commercializes a growing array of molecular diagnostic tests for cancer patients. Leveraging its unique expertise in expression profiling ...
Advancing Molecular Diagnostics in Oncology
We have published hundreds of bioTheranostics news stories on BioPortfolio along with dozens of bioTheranostics Clinical Trials and PubMed Articles about bioTheranostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of bioTheranostics Companies in our database. You can also find out about relevant bioTheranostics Drugs and Medications on this site too.
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...